Examples of 'anti-hcv' in a sentence
Meaning of "anti-hcv"
anti-hcv: an abbreviation for anti-hepatitis C virus. It refers to antibodies that target the hepatitis C virus in the body
How to use "anti-hcv" in a sentence
Basic
Advanced
anti-hcv
Followed by anti-HCV seroconversion weeks later.
Testing should be initiated with anti-HCV.
Combinations of anti-HCV antibodies are also provided.
The octamers listed below were immunoreactive with anti-HCV antisera.
These detected anti-HCV antibodies are evidence of a current or past infection.
There was no association of anti-HCV with gender or age.
If no anti-HCV antibody is present in the test specimen, no visible precipitate is formed.
We have developed a number of anti-HCV core monoclonal antibodies.
An association was observed between dialysis treatment by hemodialysis and seropositivity to anti-HCV.
In some embodiments, the anti-HCV compounds are microencapsulated by an enteric polymer.
There are not currently any satisfactory anti-HCV agents or treatments.
The prevalence of anti-HCV also increases with the duration of dialysis.
In an embodiment the other compound having anti-HCV activity is an interferon.
The anti-HCV activity of compound 8a was determined in an in vitro primary human hepatocyte assay.
The prospects for effective anti-HCV vaccines remain uncertain.
See also
Immunoblot assays are highly specific and valuable in verifying anti-HCV reactivity.
In addition to interferon, current anti-HCV treatment generally includes administering ribavirin.
Syringe sharing in prison was an independent risk factor for anti-HCV positivity.
The frequencies of anti-HCV were evaluated as well as their association with other risk factors.
Serological tests for the detection of anti-HCV antibodies have been developed.
Unfortunately, there are no serine protease inhibitors available currently as anti-HCV agents.
An immunoassay for detecting the presence of anti-HCV antibodies in a test sample comprising,.
A pharmaceutical composition according to claim 7 further comprising another anti-HCV agent.
Several studies show variable anti-HCV seroprevalence values in different dialysis centers worldwide.
Preferably, the composition further comprises a compound having anti-HCV activity.
Counseling of anti-HCV positive persons to prevent further transmission is another component of primary prevention.
In another embodiment the other compound having anti-HCV activity is a cyclosporin.
Current anti-HCV treatments comprise the administration of a combination of pegylated interferon and ribavirin.
In another embodiment the second compound having anti-HCV activity is an interferon.
Effective anti-HCV therapy is restricted to therapy with interferon or a combination of interferon and ribavirin.
The pharmaceutical composition can further comprise another anti-HCV agent.
Detecting whether anti-HCV antibody-HCV antigen complexes are formed as a result of the reacting.
Combination of biomarkers for the prognosis of response or non-response to an anti-HCV treatment.
The complexes formed comprising anti-HCV antibody are then detected by any of a number of techniques.
Exemplary compounds of the present invention were tested for their anti-HCV activities.
In other embodiments, the anti-HCV compounds may be administered separately from the carboxylesterase inhibitors.
In contrast, the increase in the level of human anti-HCV antibodies lagged dramatically.
In one embodiment, the carboxylesterase inhibitors are administered prior to administration of the anti-HCV compound.
A method for producing a hybridoma which produces anti-HCV monoclonal antibodies comprising,.
Both sofosbuvir and ledipasvir have previously been demonstrated to act as effective anti-HCV agents.
An immunoassay for anti-HCV antibody may utilize one viral epitope or several viral epitopes.
Several institutions and laboratories are attempting to identify and develop anti-HCV drugs.
The reaction specificity of the above phages with anti-HCV antibodies is evaluated statistically as follows.
The chimeric protein is suitable to develop a sensitive assay to detect anti-HCV antibodies.
Anti-human antibodies which recognize an epitope on anti-HCV antibodies will bind due to complex formation.
In the above embodiments, the additional therapeutic agent may be an anti-HCV agent.
Preferred are compositions and combinations of anti-HCV compounds and carboxylesterase inhibitors exhibiting high therapeutic indices.
Exemplary compounds of the present disclosure were tested for their anti-HCV activities.
In general, the uses comprise administering the anti-HCV compound and adjunctively administering a carboxylesterase inhibitor.
Recombinant proteins may be utilized to detect the presence of anti-HCV in test samples.
